Uncover Insights with BD-Tau and Key
Neurology Biomarkers
Flyer
Whether your research is focused on a single neurology biomarker or spans the complex interactions of multiple markers, the Simoa® Neurology 4-Plex D (N4PD) Advantage PLUS assay delivers unmatched sensitivity, efficiency, and automated precision. With the capability to simultaneously measure NfL, GFAP*, UCH-L1*, and brain-derived Tau (BDTau) in both blood and cerebrospinal fluid (CSF), this assay streamlines your workflow and accelerates the discovery of critical insights for your next breakthrough.
These four biomarkers have significant established and emerging implications across the spectrum of neurodegenerative conditions, brain injury and more. Simoa® N4PD Advantage PLUS is an innovative tool that offers broad biomarker insights with added brain specificity from BD-Tau, all within the ease of a single assay workflow and single sample input. Download our flyer to learn more.
*GFAP and UCH-L1 are offered pursuant to a license from Banyan Biomarkers, Inc. Banyan GFAP® and Banyan UCH-L1® are registered trademarks of Banyan Biomarkers.